ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,384 | -28.8% | 34,214 | 0.0% | 0.00% | – |
| Q2 2023 | $221,022 | +93.7% | 34,214 | +126.1% | 0.00% | – |
| Q1 2023 | $114,088 | -7.5% | 15,131 | +16.5% | 0.00% | – |
| Q4 2022 | $123,285 | -42.9% | 12,991 | -40.6% | 0.00% | -100.0% |
| Q3 2022 | $216,000 | -7.3% | 21,866 | +0.0% | 0.00% | 0.0% |
| Q2 2022 | $233,000 | +49.4% | 21,857 | +36.5% | 0.00% | 0.0% |
| Q1 2022 | $156,000 | -22.0% | 16,008 | +13.1% | 0.00% | 0.0% |
| Q4 2021 | $200,000 | +41.8% | 14,154 | +100.5% | 0.00% | 0.0% |
| Q3 2021 | $141,000 | -9.0% | 7,058 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $155,000 | – | 7,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |